GOLDMAN SACHS GROUP INC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$751,594
+131.4%
53,647
+70.9%
0.00%
Q2 2023$324,814
-50.2%
31,383
-55.5%
0.00%
Q1 2023$651,928
+213.1%
70,555
+200.6%
0.00%
Q4 2022$208,223
+6.2%
23,475
-0.5%
0.00%
Q3 2022$196,000
-37.4%
23,592
-38.3%
0.00%
Q2 2022$313,000
-27.9%
38,235
-23.1%
0.00%
Q1 2022$434,000
-15.4%
49,730
-7.9%
0.00%
Q4 2021$513,000
-46.7%
53,973
-5.6%
0.00%
Q3 2021$962,000
-8.7%
57,180
-17.2%
0.00%
Q2 2021$1,054,000
-47.7%
69,031
-33.2%
0.00%
-100.0%
Q1 2021$2,014,000
-36.2%
103,399
-41.0%
0.00%0.0%
Q4 2020$3,159,000
+2.6%
175,292
+9.8%
0.00%0.0%
Q3 2020$3,079,000
-17.7%
159,586
+11.4%
0.00%0.0%
Q2 2020$3,742,000
+75.4%
143,265
+19.8%
0.00%0.0%
Q1 2020$2,133,000
-32.0%
119,537
+27.2%
0.00%0.0%
Q4 2019$3,136,000
+3.8%
93,975
-25.8%
0.00%0.0%
Q3 2019$3,020,000
+45.8%
126,724
+119.8%
0.00%0.0%
Q2 2019$2,072,000
-5.6%
57,647
-3.0%
0.00%0.0%
Q1 2019$2,196,000
+215.1%
59,445
+267.4%
0.00%
Q4 2018$697,000
+20.6%
16,179
+32.2%
0.00%
Q3 2018$578,000
-23.4%
12,234
-19.4%
0.00%
Q2 2018$755,000
-66.0%
15,172
-66.1%
0.00%
-100.0%
Q1 2018$2,221,000
+849.1%
44,699
+609.5%
0.00%
Q4 2017$234,0006,3000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders